Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib

BACKGROUND AND AIM: Lenvatinib (LEN) has an antitumor effect with an early reduction in contrast enhancement for unresectable hepatocellular carcinoma (HCC). The aim of this study was to reveal the most useful radiological response evaluation for overall survival (OS) in patients treated with LEN. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Shun, Tsuchiya, Kaoru, Yasui, Yutaka, Inada, Kento, Kirino, Sakura, Yamashita, Koji, Osawa, Leona, Hayakawa, Yuka, Sekiguchi, Shuhei, Higuchi, Mayu, Takaura, Kenta, Maeyashiki, Chiaki, Tamaki, Nobuharu, Takeguchi, Takaya, Takeguchi, Yuko, Nakanishi, Hiroyuki, Itakura, Jun, Takahashi, Yuka, Himeno, Yoshiro, Kurosaki, Masayuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731835/
https://www.ncbi.nlm.nih.gov/pubmed/33319054
http://dx.doi.org/10.1002/jgh3.12420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731835/
https://www.ncbi.nlm.nih.gov/pubmed/33319054
http://dx.doi.org/10.1002/jgh3.12420

Ejemplares similares